Name : Anju Jain

(48Y/F)
Date : 04 Jun
2024
Test Asked : Aarogyam C Pro With Utsh, Mg + 1
Others
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ANJU JAIN (48Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC
: SELF
TEST 2 ROHINI,110085
ASKED : AAROGYAM C PRO WITH UTSH,MG,FBS

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
COMPLETE HEMOGRAM
HEMOGLOBIN 11.6 g/dL 12.0-15.0
LYMPHOCYTE 43.1 % 20-40
MEAN CORP.HEMO.CONC(MCHC) 30 g/dL 31.5-34.5
MEAN CORPUSCULAR VOLUME(MCV) 105.7 fL 83.0-101.0
MEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12
PLATELET DISTRIBUTION WIDTH(PDW) 18.1 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 49.8 % 19.7-42.4
RED CELL DISTRIBUTION WIDTH (RDW-CV) 15.3 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0
TOTAL RBC 3.66 X 10^6/µL 3.8-4.8
METABOLIC
MAGNESIUM 1.84 mg/dL 1.90 - 3.10

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed
report values, parameter correlation and clinical interpretation, kindly refer to the same in subsequent
pages.
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: ANJU JAIN (48Y/F)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST ASKED
: HbA1c,HEMOGRAM

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 5.3 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory
Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 105 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl :
Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 15:14
Report Released on (RRT)
: 04 Jun 2024 17:52
Sample Type
Labcode : EDTA Whole Blood Dr Saakshi Mittal Dr Neha Prabhakar
MD(Path) MD(Path)
Barcode : 0406088577/DEL46
Page : 1 of
: CE004850 14
 PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: ANJU JAIN (48Y/F)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : HbA1c,HEMOGRAM

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL LEUCOCYTES COUNT (WBC) 5.62 X 10³ / µL 4.0 - 10.0

HF & FC
NEUTROPHILS Flow Cytometry 49.6 % 40-80
LYMPHOCYTE Flow Cytometry 43.1 % 20-40
MONOCYTES Flow Cytometry 4.6 % 2-10
EOSINOPHILS Flow Cytometry 2 % 1-6
BASOPHILS Flow Cytometry 0.4 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4
Flow Cytometry

NEUTROPHILS - ABSOLUTE COUNT 2.79 X 10³ / µL 2.0-7.0

Calculated

LYMPHOCYTES - ABSOLUTE COUNT 2.42 X 10³ / µL 1.0-3.0

Calculated

MONOCYTES - ABSOLUTE COUNT 0.26 X 10³ / µL 0.2 - 1.0

Calculated

BASOPHILS - ABSOLUTE COUNT 0.02 X 10³ / µL 0.02 - 0.1

Calculated

EOSINOPHILS - ABSOLUTE COUNT 0.11 X 10³ / µL 0.02 - 0.5

Calculated

IMMATURE GRANULOCYTES(IG) 0.02 X 10³ / µL 0.0-0.3

Calculated

TOTAL RBC 3.66 X 10^6/µL 3.8-4.8

HF & EI

NUCLEATED RED BLOOD CELLS 0.01 X 10³ / µL 0.0-0.5

Calculated

NUCLEATED RED BLOOD CELLS % 0.01 % 0.0-5.0

Flow Cytometry
HEMOGLOBIN SLS-Hemoglobin Method 11.6 g/dL 12.0-15.0

HEMATOCRIT(PCV) 38.7 % 36.0-46.0

CPH Detection

MEAN CORPUSCULAR VOLUME(MCV) 105.7 fL 83.0-101.0

Calculated

MEAN CORPUSCULAR HEMOGLOBIN(MCH) 31.7 pq 27.0-32.0

Calculated
MEAN CORP.HEMO.CONC(MCHC) 30 g/dL 31.5-34.5
Calculated

RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) Calculated 59.7 fL 39.0-46.0

RED CELL DISTRIBUTION WIDTH (RDW-CV) 15.3 % 11.6-14.0

Calculated

PLATELET DISTRIBUTION WIDTH(PDW) 18.1 fL 9.6-15.2

Calculated

MEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12

Calculated

PLATELET
COUNT 155 X 10³ / µL 150-410
Remarks : HF &normocytic
Alert!!! RBCs:Mild anisopoikilocytosis. Predominantly EI normochromic with macrocytes & ovalocytes. Platelets:Appear adequate in sm
PLATELET TO LARGE CELL RATIO(PLCR) 49.8 % 19.7-42.4
Please Correlate with clinical conditions. Calculated
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)0.2
PLATELETCRIT(PCT) % 0.19-0.39
Calculated
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 15:14
Report Released on (RRT)
Sample Type : 04 Jun 2024 17:52
Labcode Dr Saakshi Mittal Dr Neha Prabhakar
: EDTA Whole Blood MD(Path) MD(Path)

Barcode : 0406088577/DEL46 Page : 2 of 14

: CE004850
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ANJU JAIN (48Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : BLOOD SUGAR (F)

TEST NAME TECHNOLOGY VALUE UNITS

FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 92.6 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed
, icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration
and reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history,
clinical
findings and other findings.

Please correlate with clinical conditions.

Method:- GOD-PAP METHOD

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
Sample Type : 04 Jun 2024 17:17
Labcode Dr Neha Prabhakar
: FLUORIDE MD(Path)
Dr Saakshi Mittal MD(Path)
: 0406091527/DEL46 Page : 3 of 14
Barcode

: BO457919
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: ANJU JAIN (48Y/F)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST ASKED
: AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) C.L.I.A 69.18 ng/mL

Bio. Ref. Interval. :
DEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml
SUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml

Clinical Significance:

Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are
critical for building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency,
nephrotic syndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml. Kit

Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.

Method : Fully Automated Chemi Luminescent Immuno Assay

VITAMIN B-12 C.L.I.A 366

pg/mL
Bio. Ref. Interval. :

Normal : 211 - 911 pg/ml

Clinical significance :
Vitamin B12 or
cyanocobalamin, is a
complex corrinoid
compound found
exclusively from animal
dietary sources, such as
meat, eggs
and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For
diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and
other findings.

Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml Kit

Validation reference:
Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby;
1987:569–73.
Method : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
: 04 Jun 2024 19:35
Sample Type
Labcode : SERUM Dr Saakshi Mittal Dr Neha Prabhakar
MD(Path) MD(Path)
Barcode : 0406091538/DEL46
Page : 4 of
: CI882401 14
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ANJU JAIN (48Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 1.38 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:

1. Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2. Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
Sample Type : 04 Jun 2024 19:35
Labcode Dr Neha Prabhakar
: SERUM MD(Path)
Dr Saakshi Mittal MD(Path)
: 0406091538/DEL46 Page : 5 of 14
Barcode

: CI882401
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ANJU JAIN (48Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS

TESTOSTERONE C.L.I.A 21.51 ng/dL
Bio. Ref. Interval. :-

Adult Male
21 - 49 Yrs : 164.94 - 753.38 || 50 - 89 Yrs : 86.49 - 788.22
Adult Female
Pre-Menopause : 12.09 - 59.46 || Post-Menopause: < 7.00 - 48.93
Boys
2-10 Years : < 7.00 - 25.91
11 Years : < 7.00 - 341.53
12 Years : < 7.00 - 562.59
13 Years : 9.34 - 562.93
14 Years : 23.28 - 742.46
15 Years : 144.15 - 841.44
16-21 Years : 118.22 - 948.56
Girls
2-10 Years : < 7.00 - 108.30
11-15 Years : < 7.00 - 48.40
16-21 Years : 17.55 - 50.41

Clinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal
males. Major causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure
Hyperprolactinema, Hypopituitarism some types of liver and kidney diseases and critical illness.

Specifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.

Kit Validation Reference: Kicklighter EJ, Norman RJ. The gonads. In: Kaplan LA, Pesce AJ, eds. Clinical Chemistry: Theory, Analysis,
Correlation. 2nd ed. St. Louis: CV Mosby; 1989:657–662.

Please correlate with clinical conditions.

Method:- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
Sample Type : 04 Jun 2024 19:35
Labcode Dr Neha Prabhakar
: SERUM MD(Path)
Dr Saakshi Mittal MD(Path)
: 0406091538/DEL46 Page : 6 of 14
Barcode

: CI882401
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: ANJU JAIN (48Y/F)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST ASKED
: AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 86.7 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 282.4 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : Spectrophotometric Assay
% TRANSFERRIN SATURATION CALCULATED 30.7 %
Bio. Ref. Interval. :
13 - 45
Method : Derived from IRON and TIBC values
UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 195.7 µg/dL
Bio. Ref. Interval. :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY
Please correlate with clinical conditions.

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
: 04 Jun 2024 19:35
Sample Type
Labcode : SERUM Dr Saakshi Mittal Dr Neha Prabhakar
MD(Path) MD(Path)
Barcode : 0406091538/DEL46
Page : 7 of
: CI882401 14
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: ANJU JAIN (48Y/F)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 170 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 48 mg/dL 40-60
HDL / LDL RATIO CALCULATED 0.52 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 93 mg/dL < 100
TRIG / HDL RATIO CALCULATED 2.1 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 101 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 3.5 Ratio 3-5
LDL / HDL RATIO CALCULATED 1.9 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 121.5 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 20.2 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
HD/LD - Derived from HDL and LDL values.
LDL - Direct Measure
TRI/H - Derived from TRIG and HDL Values
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
LDL/ - Derived from serum HDL and LDL Values
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:

TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190

Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might
fluctuate.

Sample Collected on (SCT) : 04 Jun 2024 08:50

Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
: 04 Jun 2024 19:35
Sample Type
: SERUM Dr Saakshi Mittal Dr Neha Prabhakar
Labcode
MD(Path) MD(Path)
Barcode : 0406091538/DEL46
Page : 8 of
14
: CI882401
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: ANJU JAIN (48Y/F)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 72.1 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.53 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.45 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 14.4 U/L < 38
SGOT / SGPT RATIO CALCULATED 1.37 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 21.1 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 15.4 U/L < 34
PROTEIN - TOTAL PHOTOMETRY 6.48 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.87 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.61 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.48 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 04 Jun 2024 08:50

Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
: 04 Jun 2024 19:35
Sample Type
: SERUM Dr Saakshi Mittal Dr Neha Prabhakar
Labcode
MD(Path) MD(Path)
Barcode : 0406091538/DEL46
Page : 9 of
14
: CI882401
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ANJU JAIN (48Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS

MAGNESIUM PHOTOMETRY 1.84 mg/dL
Bio. Ref. Interval. :-

1.90 - 3.10 mg/dL

Clinical significance:

Magnesium is the fourth most abundant cation in the body and second most prevalent intracellular cation. The total body
magnesium content is about 25 g or approximately 1 mol, of which 55% reside in the skeleton. About 45% of the magnesium is
intracellular. In general higher the metabolic activity of cell, the greater is its magnesium content. Magnesium is a cofactor for
more than 300 enzymes in the body.

Disorders of magnesium metabolism are separated into those causing hypomagnesaemia/magnesium deficiencies and
hypermagnesemia. Hypomagnesaemia is common in patient in hospitals. Moderate to severe deficiency of magnesium is usually
due to loss of magnesium from the gastrointestinal (gi) tract or kidneys. One of the more serious complications of magnesium
deficiency is cardiac arrhythmia. Symptomatic hypermagnsemia is almost always caused by excessive intake, resulting from
administration of antacids, enemas, and parenteral fluids containing magnesium. Depression of neuromuscular system is the
most common manifestation of magnesium intoxication.

External quality control program participation:

College Of American Pathologists: Chemistry survey; CAP Number: 7193855-01

Please correlate with clinical conditions.

Method:- MODIFIED XYLIDYL BLUE REACTION METHOD

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
Sample Type : 04 Jun 2024 19:35
Labcode Dr Neha Prabhakar
: SERUM MD(Path)
Dr Saakshi Mittal MD(Path)
: 0406091538/DEL46 Page : 10 of 14
Barcode

: CI882401
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: ANJU JAIN (48Y/F)
REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

UREA (CALCULATED) CALCULATED 26.54 mg/dL Adult : 17-43
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 12.4 mg/dL 7.94 - 20.07
UREA / SR.CREATININE RATIO CALCULATED 39.02 Ratio < 52
CREATININE - SERUM PHOTOMETRY 0.68 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 18.24 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 8.91 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4.27 mg/dL 3.2 - 6.1
SODIUM I.S.E 144 mmol/L 136 - 145
CHLORIDE I.S.E 107 mmol/L 98 - 107
Please correlate with clinical conditions.

Method :
UREAC - Derived from BUN Value.
BUN - Kinetic UV Assay.
UR/CR - Derived from UREA and Sr.Creatinine values.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method
SOD - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE

Sample Collected on (SCT) : 04 Jun 2024 08:50

Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
: 04 Jun 2024 19:35
Sample Type
: SERUM Dr Saakshi Mittal Dr Neha Prabhakar
Labcode
MD(Path) MD(Path)
Barcode : 0406091538/DEL46
Page : 11 of
14
: CI882401
 PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME SAMPLE COLLECTED AT :

: ANJU JAIN (48Y/F)
(212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
REF. BY ROHINI,110085
: SELF
TEST ASKED
: AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 76 ng/dL 58-159
TOTAL THYROXINE (T4) C.M.I.A 7.84 µg/dL 4.87-11.72
TSH - ULTRASENSITIVE C.M.I.A 1.812 µIU/mL 0.35-4.94

The Biological Reference Ranges is specific to the age group. Kindly correlate
clinically. Method :

T3,T4,USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay

Pregnancy reference ranges for TSH/USTSH :

Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as
Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian
women with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research.
2019; 6(4)

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
Report Released on (RRT) : 04 Jun 2024 16:01

Sample Type : 04 Jun 2024 19:35

Labcode : SERUM Dr Saakshi Mittal Dr Neha Prabhakar

Barcode MD(Path) MD(Path)
: 0406091538/DEL46
Page : 12 of 14
: CI882401
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ANJU JAIN (48Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST
ASKED : AAROGYAM C PRO WITH UTSH,MG

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 103 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to
routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report
the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured
easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy
to interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine
Equation

~~ End of report ~~

Sample Collected on (SCT)

: 04 Jun 2024 08:50
Sample Received on (SRT)
: 04 Jun 2024 16:01
Report Released on (RRT)
Sample Type : 04 Jun 2024 19:35
Labcode Dr Neha Prabhakar
: SERUM MD(Path)
Dr Saakshi Mittal MD(Path)
: 0406091538/DEL46 Page : 13 of 14
Barcode

: CI882401
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical
treatment. v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333

+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 14 of 14